يعرض 1 - 10 نتائج من 33 نتيجة بحث عن '"INR, International Normalised Ratio"', وقت الاستعلام: 0.85s تنقيح النتائج
  1. 1

    المصدر: JHEP Reports
    JHEP reports 4(1), 100391 (2022). doi:10.1016/j.jhepr.2021.100391

    مصطلحات موضوعية: Cirrhosis, MFI, median fluorescence intensity, sVSIG4, soluble V-set Ig-domain-containing 4, HLA-DR, human leucocyte antigen-DR isotype, INR, international normalised ratio, Complement receptor, IMC, isotype-matched control, MPLA, monophosphoryl lipid A, Gastroenterology, TNF, tumour necrosis factor, Model for End-Stage Liver Disease, Ascites, Immunology and Allergy, FMO, fluorescence minus one, MOI, multiplicity of infection, Prognostic factor, Complement component 3, qRT-PCR, quantitative real-time PCR, SBP, spontaneous bacterial peritonitis, MMP, matrix metalloproteinase, PM, peritoneal macrophage, LPS, lipopolysaccharide, Tumor necrosis factor alpha, CCR2, C-C chemokine receptor type 2, TAPI-2, tumour necrosis factor protease inhibitor 2, medicine.symptom, PAMP, pathogen-associated molecular pattern, Research Article, TLR, Toll-like receptor, medicine.medical_specialty, AF, ascitic fluid, LAMP2, lysosome-associated membrane protein 2, MELD, model for end-stage liver disease, Spontaneous bacterial peritonitis, Internal medicine, Internal Medicine, medicine, VSIG4, V-set Ig-domain-containing 4, Hepatology, business.industry, MACS, magnet-activated cell sorting, Risk of death, Biomarker, FCS, foetal calf serum, medicine.disease, PD-L1, programmed cell death 1 ligand 1, C3, complement component 3, BSA, bovine serum albumin, EEA1, early endosome antigen 1, MERTK, tyrosine-protein kinase Mer, Bacterial infection, PFA, paraformaldehyde, business, CD163

  2. 2

    المصدر: Journal of Infection and Public Health, Vol 14, Iss 11, Pp 1623-1629 (2021)
    Journal of Infection and Public Health

  3. 3

    المساهمون: Institut Català de la Salut, [Nevens F] Department of Gastroenterology and Hepatology, University Hospitals, KU Leuven, Belgium. [Gustot T] Department of Gastroenterology and Hepato-Pancreatology, C.U.B. Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium. [Laterre PF] Intensive Care Unit, Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium. [Lasser LL] Gastroenterology Clinic, CHU Brugmann, Brussels, Belgium. Department of Hepatogastroenterology, CHU Brugmann, Brussels, Belgium. [Haralampiev LE] Department of Internal Diseases, Multiprofile Hospital for Active Treatment (MEDICA), Ruse, Bulgaria. [Vargas V] Unitat del Fetge, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. CIBERehd, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, UCL - SSS/IREC/PEDI - Pôle de Pédiatrie, UCL - SSS/IREC/MEDA - Pôle de médecine aiguë, UCL - (SLuc) Service de soins intensifs, UCL - (SLuc) Service de gastro-entérologie et hépatologie pédiatrique

    المصدر: JHEP Reports
    JHEP Reports, 3 (4
    Dipòsit Digital de Documents de la UAB
    Universitat Autònoma de Barcelona
    Scientia
    JHEP Reports, Vol 3, Iss 4, Pp 100291-(2021)
    JHEP Reports, Vol. 3, no. 4, p. 100291 [1-10] (2021)

    مصطلحات موضوعية: Alcoholic liver disease, Cirrhosis, SAS, safety analysis set, EASL-CLIF, European Association for the Study of Chronic Liver Failure, MSC, mesenchymal stem cells, adverse event, INR, international normalised ratio, international normalised ratio, intravenous, RC799-869, Cèl·lules mare - Ús terapèutic - Eficàcia, Systemic inflammation, Gastroenterology, Model for End-Stage Liver Disease, ACLF, serious AE, ATMP, advanced therapy medicinal product, human allogeneic liver-derived progenitor cells, Immunology and Allergy, model for end-stage liver disease, AE of special interest, Otros calificadores::/terapia [Otros calificadores], Liver regenerative medicine, Stem cell, biology, i.v, BW, body weight, AESI, AE of special interest, SAE, Diseases of the digestive system. Gastroenterology, afecciones patológicas, signos y síntomas::procesos patológicos::atributos de la enfermedad::progresión de la enfermedad [ENFERMEDADES], EASL-CLIF, SAE, serious AE, AD, acute decompensation of liver cirrhosis, CRP, C-reactive protein, SAS, advanced therapy medicinal product, acute-on-chronic liver failure, medicine.symptom, CRP, TGT, AE, adverse event, HALPC, células::células madre [ANATOMÍA], Research Article, INR, medicine.medical_specialty, TGT, thrombin generation test, safety analysis set, European Association for the Study of Chronic Liver Failure, acute decompensation of liver cirrhosis, thrombin generation test, enfermedades del sistema digestivo::enfermedades hepáticas::insuficiencia hepática::fracaso hepático::fracaso hepático agudo::insuficiencia hepática crónica agudizada [ENFERMEDADES], C-reactive protein, MELD, model for end-stage liver disease, MSC, body weight, Internal medicine, i.v., intravenous, Internal Medicine, medicine, Decompensation, Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Disease Progression [DISEASES], BW, Adverse effect, SUSAR, mesenchymal stem cells, Hepatology, business.industry, Insuficiència hepàtica - Tractament, Digestive System Diseases::Liver Diseases::Hepatic Insufficiency::Liver Failure::Liver Failure, Acute::Acute-On-Chronic Liver Failure [DISEASES], AE, AD, TEG, thromboelastography, Généralités, Other subheadings::/therapy [Other subheadings], medicine.disease, HALPC, human allogeneic liver-derived progenitor cells, ATMP, MELD, TEG, thromboelastography, AESI, Cells::Stem Cells [ANATOMY], SUSAR, suspected unexpected serious adverse reaction, ACLF, acute-on-chronic liver failure, biology.protein, Avaluació de resultats (Assistència sanitària), suspected unexpected serious adverse reaction, Liver function, business

    وصف الملف: Electronic-eCollection; application/pdf; 1 full-text file(s): application/pdf

  4. 4

    المصدر: JHEP Reports. 4:100513

    مصطلحات موضوعية: PVT, HE, international normalised ratio, Child–Pugh score, SHR, United Network for Organ Sharing model for end-stage liver disease (2016), LT, ACLF, Immunology and Allergy, model for end-stage liver disease, portal vein thrombosis, aSHR, HCC, Portal hypertension, TFS, Baveno, UNOS MELD (2016), liver transplantation, IQR, NASH, Gastroenterology, CI, hepatocellular carcinoma, Acute kidney injury, TIPS, non-alcoholic steatohepatitis, acute-on-chronic liver failure, Hepatic decompensation, INR, adjusted subdistribution hazard ratio, interquartile range, hepatic encephalopathy, HRS-AKI, NAFLD, transjugular intrahepatic portosystemic shunt, Internal Medicine, Spontaneous bacterial peritonitis, subdistribution hazard ratio, ICA, SBP, variceal bleeding, refractory ascites, Hepatology, ACLF, acute-on-chronic liver failure, CI, confidence interval, CPS, Child–Pugh score, HCC, hepatocellular carcinoma, HE, hepatic encephalopathy, HRS-AKI, hepatorenal syndrome–acute kidney injury, ICA, International Club of Ascites, INR, international normalised ratio, IQR, interquartile range, LT, liver transplantation, MELD, model for end-stage liver disease, NAFLD, non-alcoholic fatty liver disease, NASH, non-alcoholic steatohepatitis, PVT, portal vein thrombosis, RA, refractory ascites, SBP, spontaneous bacterial peritonitis, SHR, subdistribution hazard ratio, TFS, transplant-free survival, TIPS, transjugular intrahepatic portosystemic shunt, UNOS MELD (2016), United Network for Organ Sharing model for end-stage liver disease (2016), VB, variceal bleeding, aSHR, adjusted subdistribution hazard ratio, non-alcoholic fatty liver disease, transplant-free survival, MELD, VB, confidence interval, International Club of Ascites, hepatorenal syndrome–acute kidney injury, CPS, RA

  5. 5
  6. 6

    المساهمون: Dajti E., Marasco G., Ravaioli F., Colecchia L., Ferrarese A., Festi D., Colecchia A.

    المصدر: JHEP Reports, Vol 3, Iss 3, Pp 100289-(2021)
    JHEP Reports

    وصف الملف: ELETTRONICO

  7. 7

    المصدر: JHEP Reports, Vol 3, Iss 3, Pp 100277-(2021)
    JHEP Reports

  8. 8

    المصدر: JHEP Reports
    JHEP Reports, Vol 3, Iss 4, Pp 100321-(2021)
    JHEP reports, 3
    JHEP reports, 3, 4

    وصف الملف: application/pdf

  9. 9

    المصدر: JHEP Reports, Vol 3, Iss 5, Pp 100328-(2021)
    JHEP Reports

    وصف الملف: application/pdf

  10. 10

    المصدر: JHEP Reports
    JHEP Reports, Vol 3, Iss 2, Pp 100231-(2021)
    JHEP Reports : Innovation in hepathology, Vol. 3, No 2 (2021) P. 100231